Just saying... a company doing just 2 Million Net Revs Less than RXMD for 3 Million, with no money down, should give Indication to Value of Pharmco and it's Overvalued Market Cap. Then Factor in Armens PLAN and his Value of RXMD Shareholders, going back to SEC Suspension and Basis Financial.